Dr. Anda Garay retweeted
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
In SURPASS-CVOT, Mounjaro achieved the primary objective by demonstrating a non-inferior rate of major adverse cardiovascular events (MACE-3), including cardiovascular death, heart attack or stroke vs. Trulicity
sciencedirect.com/science/ar…
Dr. Anda Garay retweeted
ICYMI: The ALPACA trial showed that among patients w/ elevated Lp(a), lepodisiran reduces mean serum concentrations of Lp(a) from 60 to 180 days after administration.
Read more ➡️ bit.ly/4j5vpNq #ACC25
Dr. Anda Garay retweeted
👍Tirzepatide is now FDA approved for obstructive sleep 😴 Apnea
GLP1 agonist
fda.gov/news-events/press-an…
Dr. Anda Garay retweeted
The benefit of #GLP1 receptor agonists extends beyond just weight loss.
⬇️ Inflammation
⬇️ Blood pressure
⬆️ Plaque stability
⬇️ Circulating lipids/fats
The 🫀 cardiovascular protection is in part weight-independent due to these protective factors.
buff.ly/3ZqVU9f
Dr. Anda Garay retweeted
¡La inflamación crónica es parte del mecanismo de envejecimiento!
De hecho, a esta inflamación crónica de bajo grado le llamamos "inflammaging"
Y resulta que ¡la IL-11 es parte de esta inflamación!
En un estudio reciente, Widjaja et al. evaluaron la inhibición genética y farmacológica de a interleucina 11 sobre el envejecimiento en ratones...y vieron que al inhibir IL-11 en ratones se incrementa el tiempo de vida y el tiempo de vida libre de enfermedad.
Dr. Anda Garay retweeted
👉Remnant Cholesterol and Long-Term Incidence of Death in Coronary Artery Disease Patients
☝️Remnant cholesterol (RC) is associated with severe clinical and atherothrombotic outcomes, including all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE).
☝️Presented findings on RC are novel in the field of coronary artery disease patients.
☝️The data presented are supported by robust methodology: a large cohort, an extended observation period, precise lipid measurements and meticulous sample handling.
@society_eas
@ATHjournal
atherosclerosis-journal.com/…
Dr. Anda Garay retweeted
La adiposopatía (tejido adiposo disfuncional) es MUCHO MÁS que hipertrofia y acumulación 🔽
Dr. Anda Garay retweeted
¡📢 La nueva sede del LXXI Congreso Internacional de Nefrología es Expo Santa Fe en la CDMX! 🎉✨ Nos vemos del 4 al 7 de diciembre para vivir una experiencia académica única 🩺📚 #Nefrología #ExpoSantaFe #CongresoInternacional #IMIN
Dr. Anda Garay retweeted
🎥 ¡Cambio de sede confirmado! 🚨 ¡Nos vemos en Expo Santa Fe del 4 al 7 de diciembre! 🗓️ No te lo pierdas, ¡dale play para conocer más! ▶️ #IMIN #Nefrología #ExpoSantaFe #CongresoInternacional #NuevaSede #Reel
Dr. Anda Garay retweeted
🙄Treatment resistant Membranous nephropathy management
doi.org/10.1093/ckj/sfad041
@CKJsocial
Dr. Anda Garay retweeted
Topline results for oral #semaglutide #CVOT #SOUL announced today by @novonordisk
🎯14% RRR in 3-point #MACE with oral #semaglutide cf. placebo on top of standard of care in people with #T2D & established #CVD and/or #CKD
Full results due 2025
Dr. Anda Garay retweeted
✨ Antithrombotic💊 in 👥 with AF & acute or chronic coronary syndromes
#AFib #cardiotips #ACS #CCS
Dr. Anda Garay retweeted
GLP-1 medications are associated with lower rates of opioid overdose and alcohol intoxication.
onlinelibrary.wiley.com/doi/…
Dr. Anda Garay retweeted
How the small intestine is spatiotemporally regulated by its unique nutritional environment @CellCellPress cell.com/cell/abstract/S0092…
Dr. Anda Garay retweeted
LDL composition is way more than it's lipidome (lipid content) which includes core cholesteryl ester (LDL-C). The LDL proteome (protein content) is usually a single apoB-100 peptide but did you know LDLs can also carry apoC-III and apoE all and on its ultra-small sub-particles apoA-I acquired from HDLs all of which affects LDL's primary function of returning cholesterol to the liver @nationallipid @society_eas @escardio @atherosociety
Dr. Anda Garay retweeted
Quick effect of a single dose of PCSK9i in the reduction in lipid-core plaques.
A must read 👇
A single dose of the PCSK9 inhibitor administered before PCI reduces the abundance of lipid-core plaques identified via NIRS-IVUS at target lesions within a very short period of 2–6 weeks
🔗atherosclerosis-journal.com/…
#Evolocumab #PCS9i @society_eas @ELS_Cardiology
Dr. Anda Garay retweeted
SESIÓN ACADÉMICA AMIMC
Tema: “DESENMASCARANDO MITOS EN INFECCIONES EN TRASPLANTADOS”
Dra. Armelle Pérez-Cortés Villalobos
University of Manitoba
24 de octubre, 20:00 hrs.
us06web.zoom.us/j/8561809343…
Dr. Anda Garay retweeted
👉Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
😀 Happy to be a co-author of this fantastic initiative and awesome manuscript!
☝️In conclusion, our cross-sectional analysis using global data and a more heterogenous population of people with familial hypercholesterolaemia, suggests that this condition is not protective against the development of type 2 diabetes. Factors known to be associated with a greater likelihood of type 2 diabetes in the general population, especially obesity, appear to be highly relevant to those with heterozygous familial hypercholesterolaemia. For patients concerned about the benefit–risk profile of statins with respect to LDL cholesterol control versus the risk of diabetes, notably the markedly increased probability of type 2 diabetes associated with obesity overshadowed the potential effect of statins on type 2 diabetes. Since lipid-lowering medication is initiated at the point of diagnosis, reaching an early diagnosis of heterozygous familial hypercholesterolaemia and helping patients to maintain control of lifestyle factors related to obesity might help to avoid the development of type 2 diabetes in those at already substantially elevated risk of atherosclerotic cardiovascular disease.
🔓Open Access
sciencedirect.com/science/ar…
@ProfKausikRay
@society_eas
@fhscglobal
@caguilarsalinas
@Marcoslimamd
@MeralKayikcoglu
@rauldsf_santos
@KarleziAlonso
@kalrasadi
@LiamBrunham
@UrhGroselj
@BNordestgaard
@ximereyes05
@maciejbanach
Dr. Anda Garay retweeted
🆕 Cardiotoxicidad por antraciclinas: Mecanismos, prevención y manejo clínico.
📕 JACC CardioOncol
🔓 Resumen del artículo en cardioteca.com/cardiologia-c…







































